Amy S. Shah, MD, MS, FNLA
- Director, Adolescent Type 2 Diabetes Program
- Director, Research Operations, Endocrinology
- Associate Program Director, BMCP T32 Training Grant
- Professor, UC Department of Pediatrics
- amy.shah@cchmc.org
- Board Certified
About
Biography
My interest in pediatric medicine began with the idea that diseases can be prevented and managed in childhood to avoid complications as adults. My career and research now focus on the complications of chronic diseases that begin in childhood. Type 2 diabetes, cholesterol issues and blood pressure problems, once thought to be adult diseases, are also seen more and more often in young people.
Currently, my research focuses on prevention of diabetes and if diabetes develops, its long-term health consequences. With my work, I try to determine how diabetes may impact the heart, brain and blood vessels. I hope to understand how to prevent diabetes in adolescents and reduce health problems in the future.
I serve as the director of the Adolescent Type 2 Diabetes Program at Cincinnati Children’s Hospital Medical Center. In this setting, my colleagues and I work as a team to discover the best medical and surgical treatments for youth with Type 2 diabetes. We have a comprehensive clinical team that includes gastroenterologists to assess for fatty liver disease, psychologists, nutritionists, certified diabetes educators and social workers. We also work with the bariatric surgery team to understand how bariatric surgery effects youth-onset Type 2 diabetes and its complications.
I have received several awards and honors, including:
- 2014 Young Investigator Award, The International Society of Pediatric and Adolescent Diabetes
- 2015 and 2016 Young Investigator Award, The National Lipid Association
- 2016 Young Physician Scientist Award, The American Society of Clinical Investigation
- 2016 Early Career Development Award, The Central Society for Clinical and Translational Research
- 2020 Nominated as a Fellow of the National Lipid Association
BA: Biology, The University of Texas at Austin, Austin, TX, 2000.
MD: St. George’s University Medical School, Grenada, West Indies, 2004.
Pediatric Residency: Loyola University Medical Center, Maywood, IL, 2007.
Endocrine Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.
Research Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2011.
MS: Clinical Research, The University of Cincinnati, Cincinnati, OH, 2011.
Certifications: The American Board of Pediatrics, Subspeciality Board in Pediatric Endocrinology, Clinical Lipidology.
Interests
Type 2 diabetes; obesity; primary and secondary lipid disorders; hypertension; general endocrinology
Services and Specialties
Endocrinology
Interests
Type 2 diabetes; type 1 diabetes; cardiovascular risk factors; lipids and lipoproteins
Research Areas
Endocrinology
Locations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
High Rate of Islets Autoimmunity in Pediatric Patients with Index Admission of Acute Pancreatitis. Pediatric Diabetes. 2023; 2023:1-9.
Weekly insulin: a paradigm shift in type 1 diabetes therapy. The Lancet. 2023; 402:1598-1599.
Prevalence of islet cell autoimmunity in paediatric patients in index cases of acute pancreatitis. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2023; 23:e34.
Household Food Insecurity and Cognition in Youth and Young Adults with Youth-Onset Diabetes. Pediatric Diabetes. 2023; 2023:1-10.
Development and Implementation of a Multidisciplinary Clinic Focused on the Care of Adolescents with Youth-Onset Type 2 Diabetes. Journal of Multidisciplinary Healthcare. 2023; 16:2799-2807.
221-OR: Retrospective Review of Genetic Mutations and Treatments in Patients with Monogenic Diabetes of the Youth (MODY). Diabetes. 2023; 72.
1115-P: Advanced Medical Therapy (AMT) for Youth-Onset Type 2 Diabetes (T2D)—Early Results from the Run-in Phase of ST2OMP. Diabetes. 2023; 72.
1105-P: Development and Implementation of a Multidisciplinary Clinic Focused on Youth-Onset Type 2 Diabetes. Diabetes. 2023; 72.
1095-P: Proteomic Analyses Identify Novel Predictors of Loss of Glycemic Control in Youth-Onset Type 2 Diabetes. Diabetes. 2023; 72.
317-OR: Metabolomic Analyses Identify Novel Predictors of Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes. Diabetes. 2023; 72.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey